These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37759289)

  • 1. Correction: Economic burden of breast cancer: a case of Southern Iran.
    Jalali FS; Keshavarz K; Seif M; Akrami M; Jafari A; Ravangard R
    Cost Eff Resour Alloc; 2023 Sep; 21(1):71. PubMed ID: 37759289
    [No Abstract]   [Full Text] [Related]  

  • 2. The Economic Burden of Breast Cancer in Iran.
    Daroudi R; Akbari Sari A; Nahvijou A; Kalaghchi B; Najafi M; Zendehdel K
    Iran J Public Health; 2015 Sep; 44(9):1225-33. PubMed ID: 26587497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic burden of major depressive disorder: a case study in Southern Iran.
    Keshavarz K; Hedayati A; Rezaei M; Goudarzi Z; Moghimi E; Rezaee M; Lotfi F
    BMC Psychiatry; 2022 Aug; 22(1):577. PubMed ID: 36042423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of colorectal cancer in Iran in 2012.
    Vahdatimanesh Z; Zendehdel K; Kbari Sari AA; Farhan F; Nahvijou A; Delavari A; Daroudi R
    Med J Islam Repub Iran; 2017; 31():115. PubMed ID: 29951416
    [No Abstract]   [Full Text] [Related]  

  • 5. The economic burden of esophageal cancer in Iran.
    Daroudi R; Nahvijou A; Arab M; Faramarzi A; Kalaghchi B; Sari AA
    Indian J Cancer; 2022; 59(4):499-506. PubMed ID: 34380822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran.
    Rezaianzadeh A; Peacock J; Reidpath D; Talei A; Hosseini SV; Mehrabani D
    BMC Cancer; 2009 Jun; 9():168. PubMed ID: 19497131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National and subnational burden of female and male breast cancer and risk factors in Iran from 1990 to 2019: results from the Global Burden of Disease study 2019.
    Aryannejad A; Saeedi Moghaddam S; Mashinchi B; Tabary M; Rezaei N; Shahin S; Rezaei N; ; Naghavi M; Larijani B; Farzadfar F
    Breast Cancer Res; 2023 Apr; 25(1):47. PubMed ID: 37101247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic Burden of Gastric Cancer: A Case of Iran.
    Eghdami A; Ostovar R; Jafari A; Palmer AJ; Bordbar N; Ravangard R
    Cancer Control; 2019; 26(1):1073274819837185. PubMed ID: 30924358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Economic Burden of Cancer in Iran during 1995-2019: A Systematic Review.
    Rezapour A; Nargesi S; Mezginejad F; Rashki Kemmak A; Bagherzadeh R
    Iran J Public Health; 2021 Jan; 50(1):35-45. PubMed ID: 34178762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct and indirect medical costs of bladder cancer in Iran.
    Raadabadi M; Daroudi R; Zendehdel K; Haghdoost AA; Ebadzadeh MR; Rashidian H
    Cost Eff Resour Alloc; 2023 Jan; 21(1):5. PubMed ID: 36647054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic Burden of Colorectal Cancer: A Case of Fars, Iran.
    Jafari A; Alamdarloo PM; Dehghani M; Bastani P; Ravangard R
    Cancer Control; 2021; 28():10732748211009952. PubMed ID: 33882706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Economic Burden of Acute Myeloid Leukemia in Iran.
    Alipour V; Rad S; Nargesi S; Mezginejad F; Jahangiri R; Dolatshahi Z; Mousavi SA; Moshkani Z
    Iran J Public Health; 2022 Nov; 51(11):2599-2607. PubMed ID: 36561245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economic burden of osteoporosis in Iran in 2020.
    Ostovar A; Mousavi A; Sajjadi-Jazi SM; Rajabi M; Larijani B; Fahimfar N; Daroudi R
    Osteoporos Int; 2022 Nov; 33(11):2337-2346. PubMed ID: 35821307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Direct Medical Costs of Breast Cancer in Iran: Analyzing the Patient's Level Data from a Cancer Specific Hospital in Isfahan.
    Davari M; Yazdanpanah F; Aslani A; Hosseini M; Nazari AR; Mokarian F
    Int J Prev Med; 2013 Jul; 4(7):748-54. PubMed ID: 24049592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic Burden of Multiple Sclerosis Drugs in Iran during 2011-2019.
    Asadollahi M; Darvishi A; Azimi A; Annabi M; Jafariazar Z; Heshmat R
    Iran J Public Health; 2023 Feb; 52(2):407-419. PubMed ID: 37089141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the Economic Burden of Lung Cancer in Iran.
    Rezaei S; Akbari Sari A; Woldemichael A; Soofi M; Kazemi A; Karami Matin B
    Asian Pac J Cancer Prev; 2016 Oct; 17(10):4729-4733. PubMed ID: 27893204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic Burden of Epidermolysis Bullosa Disease in Iran.
    Forghani SF; Jahangiri R; Ghasemi F; Shirani R; Bagheri H; Mahmoodi R; Bagheri Faradonbeh S
    Med J Islam Repub Iran; 2021; 35():146. PubMed ID: 35321378
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost analysis of breast cancer: a comparison between private and public hospitals in Iran.
    Afkar A; Jalilian H; Pourreza A; Mir H; Sigaroudi AE; Heydari S
    BMC Health Serv Res; 2021 Mar; 21(1):219. PubMed ID: 33706762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic burden of cardiovascular diseases before and after Iran's health transformation plan: evidence from a referral hospital of Iran.
    Alipour V; Zandian H; Yazdi-Feyzabadi V; Avesta L; Moghadam TZ
    Cost Eff Resour Alloc; 2021 Jan; 19(1):1. PubMed ID: 33390167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of breast cancer in Iran: a study of the Tehran population based cancer registry.
    Mousavi SM; Mohaghegghi MA; Mousavi-Jerrahi A; Nahvijou A; Seddighi Z
    Asian Pac J Cancer Prev; 2006; 7(4):571-4. PubMed ID: 17250429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.